ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA

Wang, Wei; Zhu, Xiaohui; Zhang, Xuecong; Lei, Chengyong; Zeng, Zhicheng; Lan, Xiaoliang; Cui, Wenzhi; Wang, Feifei; Xu, Shaowan; Zhou, Juan; Wu, Xuehui; Deng, Haijun; Li, Xia; Fan, Jianbing*; Ding, Yanqing*; Huang, Zhongxi*; Liang, Li*南方医科大学
Journal of Pathology2023-4DOI: 10.1002/path.6047
1被引5阅读
引用收藏
分享

摘要

For stage III colorectal cancer (CRC) patients with a high risk of recurrence, intensified adjuvant chemotherapy can improve overall survival. We aimed to develop a circulating tumor DNA (ctDNA) methylation marker model for predicting the relapse risk of stage III CRC patients. Differentially methylated markers identified between 53 normal mucosa samples and 165 CRC tissue samples, as well as between plasma samples from 75 stage I/II (early-stage) CRC patients and 55 stage IV (late-stage) CRC patients, were analyzed using Student's t-tests. The overlapping methylation markers shared by plasma and tissue samples were used to establish a methylation marker model to evaluate the tumor burden in the peripheral blood of CRC patients using the random forest method. This model was verified in the validation cohort (n = 44) and then applied to predict recurrence risk in 50 stage III CRC patients and monitor the clinical disease course in serial samples from four CRC patients. We built a five-marker-based ctDNA methylation model that had high sensitivity (84.21%) and specificity (84%) in identifying late-stage CRC in a validation cohort containing 24 stage I/II CRC patients and 20 stage IV CRC patients. The model achieved high sensitivity (87.5%) and specificity (94.12%) in predicting tumor relapse in an independent cohort of 50 stage III CRC patients and could be an independent recurrence risk factor for stage III patients [Hazard ratio (HR), 60.4; 95% confidence interval (CI): 7.68-397; p = 9.73e-5]. Analysis of serial blood samples of CRC showed that the model could monitor disease relapse earlier than imaging examination and serum carcinoembryonic antigen (CEA) and so may provide an opportunity for the early adjustment of therapeutic strategies. Moreover, the model could potentially monitor the clinical course and treatment response dynamically.

学科与关键词

关键词
colorectal cancerctDNAmethylationrecurrencerisk stratificationsurveillance
相关
加载中…
  • Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
    Yang, Xin; Wen, Xiaofeng; Guo, Qin; Zhang, Yunfeng; Liang, Zhenxing; Wu, Qian; Li, Zhihao; Ruan, Weimei; Ye, Zhujia; Wang, Hong; Chen, Zhiwei; Fan, Jian-Bing; Lan, Ping*; Liu, Huashan*; Wu, Xianrui*Clinical Epigenetics, 2022, 14(1): 160.被引 3
  • Seven DNA Methylation Biomarker Prediction Models for Monitoring the Malignant Progression From Advanced Adenoma to Colorectal Cancer
    Wang, Wei; Zhang, Xuecong; Zhu, Xiaohui; Cui, Wenzhi; Ye, Danli; Tong, Guihui; Huang, Dingpeng; Zhou, Juan; Lai, Xuwen; Yan, Guangning; Li, Xia; Fan, Jianbing*; Zhu, Hongwu*; Lei, Chengyong*Frontiers in Oncology, 2022, 12: 827811.被引 1
  • A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer
    Wu, Xianrui; Zhang, Yunfeng; Hu, Tuo; He, Xiaowen; Zou, Yifeng; Deng, Qiling; Ke, Jia; Lian, Lei; He, Xiaosheng; Zhao, Dezhi; Cai, Xuyu; Chen, Zhiwei; Wu, Xiaojian; Fan, Jian-Bing*; Gao, Feng*; Lan, Ping*Molecular Oncology, 2021, 15(10): 2702-2714.被引 29
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Pathology
发表日期
2023-04
卷期
第 259 卷, 第 4 期
页码
376-387
DOI
10.1002/path.6047
语言
ENGLISH
成果收录
SCIE
资助标注
National Key R&D program of China [2017YFC1309002]; National Natural Science Foundation of China [81672821, 81872041, 81773101, 81802306, 81903002]; Natural Science Foundation Key program of Guangdong Province of China [2018B0303110017]; Natural Science Foundation of Guangdong Province of China [2018A030310457, 2019A1515012196, 2022A1515012059]; Science and Technology Planning Project of Guangzhou [202102080525]; basic and applied basic research projects of Guangdong Province [2021A1515220040]

作者

  • W

    Wang, Wei (第一作者)

    southern med univ

  • Z

    Zhu, Xiaohui

    southern med univ

查看全部 17 位作者收起作者
  • Z

    Zhang, Xuecong

    southern med univ

  • L

    Lei, Chengyong

    southern med univ

  • Z

    Zeng, Zhicheng

    southern med univ

  • L

    Lan, Xiaoliang

    southern med univ

  • C

    Cui, Wenzhi

  • W

    Wang, Feifei

    southern med univ

  • X

    Xu, Shaowan

    southern med univ

  • Z

    Zhou, Juan

  • W

    Wu, Xuehui

    southern med univ

  • D

    Deng, Haijun

    southern med univ

  • L

    Li, Xia

  • F

    Fan, Jianbing (通讯)

    southern med univ

  • D

    Ding, Yanqing (通讯)

    southern med univ

  • H

    Huang, Zhongxi (通讯)

    southern med univ

  • L

    Liang, Li (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417